Arushi Khurana, Allison C Rosenthal, Razan Mohty, Mamatha Gaddam, Radhika Bansal, Matthew A Hathcock, Adrienne N Nedved, Urshila Durani, Madiha Iqbal, Yucai Wang, Jonas Paludo, J C Villasboas, David Dingli, Taxiarchis Kourelis, Nelson Leung, Hassan Alkhateeb, Michael W Ruff, Alice Gallo de Moraes, Paschalis Vergidis, Joerg Herrmann, Saad S Kenderian, N Nora Bennani, Patrick B Johnston, Stephen M Ansell, Yi Lin
{"title":"Chimeric antigen receptor T-cell therapy associated hemophagocytic lymphohistiocytosis syndrome: clinical presentation, outcomes, and management.","authors":"Arushi Khurana, Allison C Rosenthal, Razan Mohty, Mamatha Gaddam, Radhika Bansal, Matthew A Hathcock, Adrienne N Nedved, Urshila Durani, Madiha Iqbal, Yucai Wang, Jonas Paludo, J C Villasboas, David Dingli, Taxiarchis Kourelis, Nelson Leung, Hassan Alkhateeb, Michael W Ruff, Alice Gallo de Moraes, Paschalis Vergidis, Joerg Herrmann, Saad S Kenderian, N Nora Bennani, Patrick B Johnston, Stephen M Ansell, Yi Lin","doi":"10.1038/s41408-024-01119-2","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":8989,"journal":{"name":"Blood Cancer Journal","volume":"14 1","pages":"136"},"PeriodicalIF":12.9000,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11319601/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Cancer Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41408-024-01119-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
期刊介绍:
Blood Cancer Journal is dedicated to publishing high-quality articles related to hematologic malignancies and related disorders. The journal welcomes submissions of original research, reviews, guidelines, and letters that are deemed to have a significant impact in the field. While the journal covers a wide range of topics, it particularly focuses on areas such as:
Preclinical studies of new compounds, especially those that provide mechanistic insights
Clinical trials and observations
Reviews related to new drugs and current management of hematologic malignancies
Novel observations related to new mutations, molecular pathways, and tumor genomics
Blood Cancer Journal offers a forum for expedited publication of novel observations regarding new mutations or altered pathways.